NCT05865002View on ClinicalTrials.gov

A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)

PHASE1RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 5, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2027

Conditions
Relapsed Malignant Solid Neoplasm
Interventions
DRUG

AUR107

Once daily

Trial Locations (8)

110029

RECRUITING

All India Institute of Medical Sciences, New Delhi

395002

RECRUITING

Unique Hospital Multispeciality and Research Institute, Surat

411001

RECRUITING

Grant Medical Foundation Ruby Hall Clinic, Pune

431001

RECRUITING

Krupamayi Hospital, Aurangabad

520002

NOT_YET_RECRUITING

HCG City Cancer Centre, Vijayawada

530040

RECRUITING

Omega Hospital, Visakhapatnam

560066

RECRUITING

Vydehi Institute of Medical Sciences and Research Centre, Bangalore

570001

RECRUITING

K R Hospital, Mysore

Sponsors
All Listed Sponsors
lead

Aurigene Discovery Technologies Limited

INDUSTRY